‘For-benefit’ pharma company launched

Professor Bruce Mann
This week’s launch of Australia’s first ‘for-benefit’ pharmaceutical company is ushering in a new era of social enterprise that’s set to challenge the conventional for-profit pharma model, say stakeholders. For Benefit Medicines’ purpose is to distribute equally, 100% of profits generated from the sale of their two aromatase inhibitors, Anastrozole FBM and Letrozole FBM, to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Vic Govt invests in super pharmacy, pharmacist jabs; AMA infuriated
Next New focus on Aboriginal heart health needed